Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.

MLA

Danis, Ronald P., et al. “Anatomical Effects of Dexamethasone Intravitreal Implant in Diabetic Macular Oedema: A Pooled Analysis of 3-Year Phase III Trials.” The British Journal of Ophthalmology, vol. 100, no. 6, June 2016, pp. 796–801. EBSCOhost, https://doi.org/10.1136/bjophthalmol-2015-306823.

APA

Danis, R. P., Sadda, S., Li, X.-Y., Cui, H., Hashad, Y., & Whitcup, S. M. (2016). Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials. The British Journal of Ophthalmology, 100(6), 796–801. https://doi.org/10.1136/bjophthalmol-2015-306823

Chicago

Danis, Ronald P, Srinivas Sadda, Xiao-Yan Li, Harry Cui, Yehia Hashad, and Scott M Whitcup. 2016. “Anatomical Effects of Dexamethasone Intravitreal Implant in Diabetic Macular Oedema: A Pooled Analysis of 3-Year Phase III Trials.” The British Journal of Ophthalmology 100 (6): 796–801. doi:10.1136/bjophthalmol-2015-306823.